HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Rheumatology Network's Top 5: February 12, 2021

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending February 12, 2021.

1: Rheumatoid Arthritis Quiz: Reducing Risk of Serious Infections in RA

Patients with rheumatoid arthritis are known to have a greater risk of serious infections related both to the disease itself and its treatment. What can be done to reduce that risk? Test your knowledge with this quiz.

2: Arthur Kavanaugh, MD: Rheumatology Winter Clinical Symposium

This week we sat down for an interview with Arthur Kavanaugh, MD, to discuss his presentations for the Rheumatology Winter Clinical Symposium. He is currently the chairman for the 2021 conference. Kavanaugh is Professor of Medicine and Director of the Center for Innovative Therapy at UC San Diego. He will be presenting his findings on Rheumatology 2020: A Year in Review for rheumatoid arthritis, spondylarthritis, and psoriatic arthritis. We discuss what sets RWCS apart from other conferences and the exciting content that participants can expect.

3: Combatting Sedentary Behavior in Patients With Knee Osteoarthritis or Replacement

Investigators set out to explore sedentary behavior, physical and mental limitations, the willingness of this patient population to engage in more regular exercise, how perceptive they were to using technology to support a more active lifestyle, and interventions to reduce sedentary time.

4: Roy Fleischmann, MD: Rheumatology Winter Clinical Symposium

Rheumatology Network interviewed Roy Fleischmann, MD, to discuss his presentations for the Rheumatology Winter Clinical Symposium. He is presenting his findings on Combination Therapy in Rheumatology and Rheumatology 2020: A Year in Review of Novel Therapies.

5: Rheumatology Policy and Reimbursement: What Changed and What to Expect in 2021

Dr David R. Karp, president of the American College of Rheumatology (ACR), outlines some of the legislative and regulatory developments of last year that had significant impacts on rheumatology practices and provides a policy outlook for the year ahead.